cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Abbott Laboratories
310 own
242 watching
Current Price
$98.15
$-0.78
(-0.79%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
180,013.01M
52-Week High
52-Week High
115.83000
52-Week Low
52-Week Low
93.25000
Average Volume
Average Volume
4.36M
Dividend Yield
Dividend Yield
0.014473
P/E Ratio
P/E Ratio
30.7148
iconMarket Capitalization180,013.01M
icon52-Week High115.83000
icon52-Week Low93.25000
iconAverage Volume4.36M
iconDividend Yield0.014473
iconP/E Ratio30.7148
What does the Abbott Laboratories do?
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Read More
How much money does Abbott Laboratories make?
News & Events about Abbott Laboratories.
PR Newswire
2 months ago
Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker PR Newswire ABBOTT PARK, Ill., July 5, 2023 Abbott's breakthrough technology enables the world's first beat-to-beat, wireless communication...
PR Newswire
2 months ago
Abbott Hosts Conference Call for Second-Quarter Earnings Abbott Hosts Conference Call for Second-Quarter Earnings PR Newswire ABBOTT PARK, Ill., June 29, 2023 ABBOTT PARK, Ill., June 29, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2023 financial results on Thursday...
Accesswire
2 months ago
ARLINGTON, VA and ABBOTT PARK, IL / ACCESSWIRE / June 28, 2023 / Abbott:AbbottOn June 24, the American Diabetes Association® (ADA) and Abbott announced a collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people...
Zolmax
3 months ago
City Holding Co. grew its holdings in Abbott Laboratories (NYSE:ABT Get Rating) by 0.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 47,258 shares of the healthcare product makers stock ...
Ticker Report
3 months ago
Valeo Financial Advisors LLC raised its position in shares of Abbott Laboratories (NYSE:ABT Get Rating) by 7.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,396 shares of the healthcare ...
Frequently Asked Questions
Frequently Asked Questions
What is Abbott Laboratories share price today?
plus_minus_icon
Can Indians buy Abbott Laboratories shares?
plus_minus_icon
How can I buy Abbott Laboratories shares from India?
plus_minus_icon
Can Fractional shares of Abbott Laboratories be purchased?
plus_minus_icon
What are the documents required to start investing in Abbott Laboratories stocks?
plus_minus_icon
What is today’s traded volume of Abbott Laboratories?
plus_minus_icon
What is today’s market capitalisation of Abbott Laboratories?
plus_minus_icon
What is the 52-Week High and Low Range of Abbott Laboratories?
plus_minus_icon
What percentage is Abbott Laboratories down from its 52-Week High?
plus_minus_icon
What percentage is Abbott Laboratories up from its 52-Week Low?
plus_minus_icon
Current Price
$98.15
$-0.78
(-0.79%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
General Motors Co.
General Motors Co.
$32.58
$-0.13 (-0.40 %)
Merck & Co. Inc.
Merck & Co. Inc.
$106.34
$-0.39 (-0.37 %)
Medtronic PLC
Medtronic PLC
$80.27
$-0.19 (-0.24 %)
Johnson & Johnson
Johnson & Johnson
$160.50
$-1.16 (-0.72 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
General Motors Co.
General Motors Co.
$32.58
$-0.13 (-0.40 %)
Merck & Co. Inc.
Merck & Co. Inc.
$106.34
$-0.39 (-0.37 %)
Medtronic PLC
Medtronic PLC
$80.27
$-0.19 (-0.24 %)
Johnson & Johnson
Johnson & Johnson
$160.50
$-1.16 (-0.72 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00